CLGN - Rasio rega marang prakiraan pendapatan CollPlant Ltd
The primary driver for CollPlant Biotechnologies (CLGN) is its monopoly right to rhCollagen produced in tobacco. The forward P/S trend on the GURU.Markets terminal chart confirms this, where the 27.20 mark serves as the current indicator. Revenues are based on the supply of biomaterials for organ 3D printing and cosmetology. High B2B confidence from global corporations in the company's regenerative technologies opens significant growth prospects.
collplant.com - rincian analitis lan metrik utama (CLGN)
- rega pasar lan target rega analis:
- statistik kapitalisasi pasar:
- indikator nilai buku ekuitas:
- indikator beban utang lan likuiditas:
Utang marang Ekuitas CollPlant Biotechnologies|CLGN - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas CollPlant Biotechnologies Ltd.|CLGN - Tanggungan utang kumulatif perusahaan|Utang marang nilai buku CLGN|CLGN - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan CollPlant Biotechnologies|Rasio cepet collplant.com
- data bathi bisnis lan rasio investasi:
CLGN - Asil keuangan resik|Bathi sing dikarepake CollPlant Biotechnologies|CLGN - Kapitalisasi marang bathi|Prakiraan rega marang bathi CollPlant Biotechnologies Ltd.|CLGN - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA CLGN|CLGN - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) CollPlant Biotechnologies|CLGN - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan collplant.com|CLGN - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep CollPlant Biotechnologies
- indikator pendapatan dodolan lan penghasilan bisnis:
Analisis umum perusahaan:CollPlant Ltd (CLGN)
CollPlant Biotechnologies leads the regenerative medicine segment by creating innovative bio-inks from plant-based collagen. The company's forward P/S trend reflects the market value of the business relative to expected revenue, allowing investors to assess the asset's degree of overheating or its growth potential based on current sales forecasts and current share prices.
Pesaing wigati
Rasio rega marang prakiraan pendapatan HCA Healthcare HCA|Tenet Healthcare Corp - Rasio rega marang prakiraan pendapatan|FMS - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan SOLV|Encompass Health (EHC) - Rasio rega marang prakiraan pendapatan|UHS (Universal Health Services, Inc.) - Rasio rega marang prakiraan pendapatan|DVA (DaVita) - Multiplikator Forward P/S|Multiplikator Forward P/S RadNet Inc|Rasio rega marang prakiraan pendapatan Option Care Health Inc (OPCH)|Surgery Partners Group - Kapitalisasi marang prakiraan pendapatan|Premier, Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake EYE (nationalvision.com)|PGNY: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan ARDT (Ardent Health)|SEM: Multiplikator Forward P/S|ASTH (Astrana Corp) - Rasio rega marang prakiraan pendapatan|MD (Pediatrix Corp) - Multiplikator Forward P/S|US Physical Therapy Inc (USPH) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan The Pennant Group (PNTG)|ORGO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Nutex Health Corp - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake AUNA (Auna Corp)|SBC Medical Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep evolus.com|CYH: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan BeautyHealth|MDWD (MediWound Ltd) - Multiplikator Forward P/S|BTMD: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan The Joint Corp. (JYNT)|docgo.com - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan P3 Health Partners PIII|Gain Therapeutics Inc. (GANX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|EUDA - Rasio rega marang prakiraan pendapatan|BMGL: Rasio rega marang prakiraan pendapatan|Cuprina Holdings (Cayman) Ltd (CUPR) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep concordmedical.com (CCM)|AMS (American Shared Hospital Services) - Multiplikator Forward P/S|MRM - Prakiraan rega marang pendapatan|Multiplikator Forward P/S ALBT|Rasio kapitalisasi marang dodolan sing dikarepake DIH Group|Multiplikator Forward P/S XAGE (Longevity Health Holdings)|newgenivf.com (NIVF) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ATIP - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake CareMax Inc. CMAX|KDLY: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan ModivCare Corp|Rasio rega marang prakiraan pendapatan Novo Integrated Sciences|Rasio rega marang prakiraan pendapatan SSY|Multiplikator Forward P/S BACK
